Categories
Health

A New Possibility for Morning-After Contraception?

Only two forms of birth control the morning after are approved by the Food and Drug Administration. Both hormones are taken orally as pills: levonorgestrel (Plan B One-Step and other brands, available without a prescription) and ulipristal acetate (Ella, available by prescription). Observational studies suggest that a non-hormonal copper intrauterine device (ParaGard) may also be effective.

Now researchers have found that another type of IUD containing the hormone levonorgestrel (Liletta and other brands) works just as well as the copper IUD, and possibly even better than the FDA-approved oral pregnancy prevention pills.

The study in the New England Journal of Medicine tested the copper IUD in a randomized study against intrauterine levonorgestrel. The researchers recruited 638 women to seek emergency contraception at three family planning clinics in Utah and randomly assigned them to one device or another.

After one month, there were no pregnancies in women using the copper IUD and one in those using the hormonal IUD. The researchers calculate that the incidence of pregnancy with intrauterine levonorgestrel is 0.3 percent, compared with 1.4 to 2.6 percent with oral contraceptives.

None of the IUDs are now approved for emergency contraception, but the study’s lead author, Dr. David K. Turok, Associate Professor of Obstetrics and Gynecology at the University of Utah, expects professional guidelines to take them up soon.

“The main thing is that this is another option that can be very attractive,” he said. “Now we have a well-designed and conducted study that shows it can be used.”

Categories
Health

U.S. experiences document variety of Covid deaths in January

Lila Blanks holds the coffin of her husband Gregory Blanks, 50, who has died of coronavirus disease (COVID-19), before his funeral in San Felipe, Texas, USA, on January 26, 2021.

Callaghan O’Hare | Reuters

The United States started 2021 with the deadliest month of the coronavirus pandemic yet.

The January death toll has already surpassed the previous record number of deaths in December, according to Johns Hopkins University, when over 77,400 people died of Covid-19 in the United States. According to the data, the pandemic has killed more than 79,200 people so far this month.

In the past seven days, the country has reported an average of more than 3,300 deaths from Covid-19 per day, according to Hopkins, up 12% from a week ago.

There is hope that the death toll will slow in the coming weeks. The number of new cases reported daily in the US, which epidemiologists use as a leading indicator of whether the outbreak is increasing or decreasing, has steadily declined in recent days as an increase from interstate travel and holiday celebrations appears to be easing.

The U.S. reported about 146,600 new cases Tuesday, bringing the Hopkins average from seven days to just over 166,300 and about 17% from a week, according to Hopkins.

The number of people currently hospitalized with Covid-19 in the United States is also falling, but remains worryingly high. More than 108,900 people were hospitalized with the disease on Tuesday, according to data from the COVID Tracking Project, which was set up by journalists in the Atlantic. That’s not the high point of the more than 130,000 hospital patients reported earlier this month.

However, the potential spread of new, contagious strains of virus in the US, coupled with a slower-than-expected vaccine adoption, threatens to reverse advances in combating the outbreak.

First discovered in the United Kingdom and become the dominant strain there, the B.1.1.7 strain of the virus has been found in a number of states in the United States. Epidemiologists say the strain appears to be spreading more easily, and British officials have said it could also be more deadly.

As of Monday, the Centers for Disease Control and Prevention said 293 cases related to this strain of the virus had been found in the United States, mainly in Florida and California.

Earlier this week, the Minnesota Department of Health confirmed the first known US case of another strain of the virus that was originally discovered in Brazil. Another so-called worrying variant, named 501Y.V2 or B.1.351 depending on the epidemiologist, was first discovered in South Africa and worries scientists, since vaccines and drugs against this strain seem to be less effective. No cases related to this strain have been discovered in the United States

To curb the spread of the virus and especially the importation of new strains, President Joe Biden banned most non-US citizens traveling from South Africa from entering the US earlier this week, and increased travel restrictions for Europe, the UK and Brazil.

The president painted a dire picture of the outbreak, saying on Monday that the US “will see between 600,000 and 660,000 deaths before we start turning the corner on a large scale”.

While Biden urges people to wear masks and follow public health measures like social distancing, he is working to push the adoption of the Covid vaccines and blaming the Trump administration for the initially slow pace. On Monday, he said the US could surpass 1.5 million vaccinations per day, compared to its previous target of 1 million per day, which the last administration had almost reached.

“Time is of the essence,” he said earlier this week. “We are trying to get at least 100 million vaccinations in 100 days and move in the next 100 days where we are way beyond that to get to the point where we can get herd immunity in a country.” of over 300 million people. “

On Tuesday, he said the government was working to buy an additional 200 million doses of Pfizer’s and Moderna’s vaccines, increasing US supply from 400 million doses to 600 million, although that won’t speed up the pace of vaccinations anytime soon. He also said the administration will increase the number of cans shipped to states each week by about 20%. Some states have stated that they are able to vaccinate more people but are limited by the supply.

Categories
Health

A ‘Child’ Aspirin a Day Might Assist Forestall a Second Being pregnant Loss

For women who have had a pregnancy loss and are trying to get pregnant again, a simple routine can increase their chances: taking one baby aspirin a day.

A previous randomized study suggested that aspirin had no beneficial effects. However, re-analysis of the data, focusing on women who strictly adhere to the dosage, shows that an 81-milligram daily tablet taken while trying to conceive and throughout pregnancy is highly effective is. The new report is in the Annals of Internal Medicine.

The re-analysis included 1,227 women aged 18 to 40 who had one or two pregnancy losses and were trying to get pregnant again. The researchers found that taking a baby aspirin five to seven days a week resulted in eight more pregnancies, 15 more live births, and six fewer pregnancy losses per 100 women in the study compared to placebo. The key was strict adherence to the aspirin regime.

Women who were most attached were more likely to be married, non-Hispanic and white, of higher socio-economic status and fewer smokers. The association of daily aspirin consumption with a successful pregnancy was evident even after controlling for these factors.

Lead author, Ashley I. Naimi, associate professor of epidemiology at Emory University, warned that the results only apply to women who have lost one or two pregnancies, but those women, he said, “could be considered low-dose aspirin there pull are no other contraindications to the use of aspirin. “Ask your doctor about taking a low dose daily aspirin.

Categories
Health

Tilray inventory soars, firm to offer medical hashish in French examine

A worker inspects cannabis plants in the grow room of Aphria Inc.’s diamond factory in Leamington, Ontario, Canada on Wednesday, January 13, 2021. Tilray Inc. and Aphria Inc. have agreed to combine their activities to form a new giant in the fast growing cannabis industry.

Annie Sakkab | Bloomberg | Getty Images

Shares in Canadian cannabis company Tilray rose nearly 10% Tuesday after it was announced that the French government had been using it to provide cannabis for medical experiments.

The French National Agency for the Safety of Medicines and Health Products will start the 18- to 24-month study in the first quarter. Tilray’s products will treat patients with neuropathic pain, epilepsy and multiple sclerosis that are not relieved by existing treatments.

Tilray will export the medical cannabis products from its facility in Cantanhede, Portugal, which serves as the central research and development center for medical cannabis.

“Today’s announcement marks another milestone for Tilray as we expand our operations in Europe,” said Brendan Kennedy, Tilray chief executive.

Tilray stock is down about 2% in the past 12 months, increasing its market value to $ 2.53 billion.

Categories
Health

With All Eyes on Covid-19, Drug-Resistant Infections Crept In

“We saw a bloom in Candida auris,” said Dr. Rubin, who attributed the change to a handful of factors, particularly the challenges in testing for germs when so much testing resources went towards Covid-19.

Harmful drug-resistant bacteria are also emerging, including carbapenem-resistant Acinetobacter baumannii, which is classified as an “Urgent Health Threat” by the Centers for Disease Control and Prevention. In December, the CDC reported a group of Acinetobacter baumannii during a surge in Covid-19 patients in a New Jersey urban hospital with about 500 beds. The hospital was not identified. The bacterium Klebsiella pneumoniae spread to hospitals in Italy and Peru.

Recognizing the problem, three major medical societies sent a letter to the Centers for Medicare and Medicaid Services on Dec. 28, demanding a temporary suspension of the regulations that tie reimbursement rates to hospital-acquired infections. The three groups – the Society of Healthcare Epidemiology of America, the Society of Infectious Diseases Pharmacists, and the Association for Infection Control and Epidemiology – feared that infection rates might have increased due to Covid-19.

“The staff, care, care locations and standard patient care practices have all changed during this extraordinary period,” the letter said.

Not all types of drug-resistant infections have increased. For example, some research shows that the rate of hospital patients acquiring the bacterium Clostridioides difficile did not change much during the pandemic – a finding that suggests that the long-term effects of the pandemic on these infections overall are not yet clear.

Dr. Huang and other experts said they are not claiming the priority in fighting Covid-19 was wrong. Rather, they say that drug-resistant germs need renewed attention. Previous research has shown that up to 65 percent of nursing home residents carry some form of drug-resistant infection.

Over the years, critics have alleged that hospitals, and especially nursing homes, have been negligent in their efforts to combat these infections because of the cost of disinfecting equipment, training staff, isolating infected patients, and checking for germs.

Categories
Health

3M CEO Mike Roman expects robust Covid demand for N95s all through 2021

Mike Roman, chairman and CEO of 3M, said Tuesday the industrial giant expects demand for its N95 respirators to be robust through 2021, even as Covid vaccine delivery raises hopes that the intensity the pandemic is gradually subsiding.

The medical masks are considered the best option to protect against infection and have been in need – and sometimes in shortage – throughout the health crisis. 3M, based in St. Paul, Minnesota, began increasing production of N95 about a year ago when the novel coronavirus, which first appeared in China in late 2019, was a global concern.

“We expect the demand for our N95 respirators to be strong later this year,” Roman said Tuesday on CNBC’s Squawk on the Street. “We see the demand and needs of healthcare workers and first responders at the forefront. That is still our priority. We are focused on serving their demand as well as some critical industries that need this N95 protection.”

Roman’s comments came after 3M reported better-than-expected fourth-quarter results. Sales of $ 8.58 billion beat Wall Street’s projections of $ 8.4 billion, while earnings per share of $ 2.38 were 23 cents above estimates.

For the full year, 3M saw 12.3% sales growth in healthcare, which includes respirators and products such as hand sanitizers. The company’s total revenue of $ 32.2 billion in 2020 increased 0.1% from 2019.

3M distributed 2 billion respirators worldwide last year.

In addition to the short-term need for masks, Roman said another factor likely to fuel continued demand is governments looking to replenish their stocks. For example, the Associated Press reported in August that the US government’s national supply of personal protective equipment for health workers was nearly depleted at the time.

3M’s shares rose about 3% to nearly $ 176 apiece on Tuesday – basically unchanged since the start of the year and down slightly over the past 12 months.

Categories
Health

Hong Kong’s First Covid-19 Lockdown Exposes Deep-Rooted Inequality

HONG KONG – When Shirley Leung, 60, woke up in Hong Kong’s first coronavirus lockdown, she overlooked the tiny room she shares with her adult son, which can accommodate a single bed, cardboard boxes and plastic tubs for storing clothes.

She tried to ignore the smell of the ceiling and walls covered with mold. She rationed the fresh vegetables she had at home, dissatisfied with the canned goods and instant noodles the government had provided when it imposed restrictions on Saturday. She looked at the cramped, interconnected nature of her home.

“If a room is infected, how is it possible that cases do not spread to compartmentalized apartments?” Ms. Leung said in a telephone interview. “How can it be safe?”

Hong Kong has long been one of the most unequal places in the world, a city where sleek luxury shopping malls rub shoulders with overcrowded tenement houses, where the bathroom sometimes doubles as a kitchen. In normal times, this inequality is often masked by the glittering surface of the city. But during the coronavirus pandemic, its cost has become unmistakable.

From January 1 to the end of last week, more than 160 confirmed cases were found in the Jordanian neighborhood, out of about 1,100 across the city. The government responded by locking down 10,000 residents in an area of ​​16 blocks. More than 3,000 workers, many in protective suits, came to the area to conduct mass tests.

Hong Kong executive director Carrie Lam said Tuesday the lockdown had been a success, adding that more may follow. Officials announced one soon after in nearby Yau Ma Tei.

Officials suggested that the dilapidated living conditions of many of Jordan’s residents fueled the spread of the virus. Jordan is a crowded neighborhood known for its bustling night market, aging high-rise apartments, and numerous restaurants. This is where some of the city’s highest concentrations of rental apartments are located, the subdivided apartments that are created when apartments are divided into two or more smaller ones.

More than 200,000 of the city’s poorest residents live in units where the average living space per person is 48 square feet – less than a third the size of a parking lot in New York City. Some rooms are so small and restrictive that they are called cages or coffin houses.

The same conditions that may have led to the outbreak also made the lockdown particularly painful for many residents who worried about missing even a work day or feared being trapped in poorly ventilated breeding grounds of transmission. Officials admitted that they did not know exactly how many people were living in the compartmentalized apartments, which made efforts to test everyone difficult. Discrimination against low-income South Asian residents, many of whom are concentrated in the region, has also created problems.

Some have accused the government of tightening conditions for an outbreak and then imposing persistent measures on a group that can least afford to endure them. Wealthy Hong Kongers have caused outbursts of their own or disregarded socially distant rules with no similar consequences.

“If they did something wrong, it is to be poor, to live in a compartmentalized apartment, or to have a different skin color,” said Andy Yu, an elected officer in the restricted area.

The divided apartments have been a cause for concern since the pandemic began.

Ms. Leung, the retiree, and her son have only one bed to sleep in at night, and their son sleeps during the day after returning from night shifts as a construction worker. A roof beam was cracked, but the landlord had postponed repairs, she said. Shape was also a persistent problem as dirty water dripped from an adjacent unit.

Installation in subdivided apartments is often reconfigured to allow for more bathrooms or kitchens. However, the installation is often incorrect. During the 2002/03 SARS outbreak, more than 300 people were infected in a housing estate and 42 died after the virus spread through broken pipelines.

The government promised reforms after SARS but has recognized that the situation remains dangerous.

“Many of the buildings in the exclusion zone are older and in poor condition,” said Sophia Chan, the secretary for nutrition and health, on Saturday. “The risk of infection in the community is very high.”

The lockdown ultimately lasted only two days until midnight on Sunday the government said it had successfully tested most of the region’s residents. Thirteen people tested positive.

Updated

Jan. 26, 2021, 11:30 p.m. ET

However, experts said the government failed to address the underlying issues.

Wong Hung, deputy director of the Institute of Health Equity at Hong Kong University of China, said the government had not adequately regulated the compartmentalized housing.

“They fear that if they do something, there will be no place where low-income families can find shelter,” said Professor Wong. The real estate market in Hong Kong is consistently rated as the least affordable in the world.

Income inequality in Hong Kong is also closely linked to ethnicity, and the pandemic has exacerbated longstanding discrimination against South Asian residents, who make up around 1 percent of the city’s population. Almost a third of South Asian families with children in Hong Kong are below the poverty line, which, according to government data, is almost twice the proportion of all families in the city.

Many South Asians live in and around Jordan, including in divided dwellings, and as the virus spread, some locals made widespread allegations of unsanitary behavior.

Raymond Ho, a senior health official, was outraged last week when he suggested that Hong Kong’s ethnic minorities boost transmission because “they like to eat, smoke, drink alcohol and chat together”. Ms. Lam, the city’s leader, later said the government had not suggested that the spread of the disease was race related.

Sushil Newa, the owner of a brightly painted Nepalese restaurant in the exclusion zone, showed screenshots on his phone from online commentators comparing his community to animals and suggesting that they be alcoholics.

“We just work hard and pay taxes here. How come we are isolated from Hong Kong?” said Mr. Neva, referring to the discrimination when a clerk shoveled containers of biryani to take away.

Professor Wong said the government also failed to communicate effectively with residents of South Asia, which has led to confusion about the lockdown. The government later said it had sent translators. Other residents said the government provided Muslims with food that was not culturally appropriate, such as pork.

Even so, Mr Neva said he supported the lockdown. Although he lost money, controlling the outbreak is more important, he said.

Other entrepreneurs agreed, but also demanded compensation from the government.

Low Hung-kau, the owner of a corner stall, Shanghai Delicious Foods, said he was forced to ditch ingredients he had prepped for steamed buns – an added blow to the decline in business since the neighborhood outbreak began .

“I’ve lost 60 percent of my business,” he said. “Hardly anyone comes over.”

He spent the day after the lockdown gathering neighboring business owners to ask the government to pay at least some of their losses over the weekend. Government officials have dodged questions about compensation, only hoping employers would not deduct the salaries of workers who missed their jobs.

Activists criticized the government for its relief efforts throughout the pandemic, noting that it did not offer unemployment benefits. In addition, much of the state aid was directed towards employers rather than employees. Some companies have applied for subsidies to keep employees on payroll and then declined that promise.

Despite the risks, some had no choice but to break the lock.

Ho Lai-ha, a 71-year-old street cleaner, said she swept streets and cleared sewers over the weekend just days after they were identified as potential sources of contamination.

“I’m a little scared, but there is no other way,” she said as she dipped a duster into an open grate on Monday. “The area has been closed, but our work continues.”

Categories
Health

Financial system may open up by late spring if sufficient individuals get vaccinated, says Dr. Ashish Jha

Dr. Ashish Jha told CNBC’s “The News with Shepard Smith” on Tuesday that US states could make decisions about opening up businesses and economies earlier than predicted if enough people are vaccinated.

“My relatively optimistic view is that we don’t have to wait until the end of summer or even the beginning of summer. If enough people have been vaccinated in late spring, you will really see case numbers come down a lot,” said Jha, dean of the School of Public Health at Brown University. “That will allow us to open up the economy a lot more so that we don’t have to wait and just make sure the infections – the high infection rates we have right now – get better . “

President Joe Biden set a benchmark in the fight against the coronavirus pandemic. He promised to get enough vaccine doses to the states for almost every American by the end of summer. Biden said he would give the government another 200 million doses of the vaccine – half from Pfizer and the other half from Moderna. The deal would increase the country’s vaccine supply to 600 million shots.

“This is enough vaccine to fully vaccinate 300 [million] Americans by the end of summer, the beginning of autumn, “Biden said at the White House on Tuesday.

To vaccinate 300 million people by September 22, the last day of summer, the nation will need 600 million doses at the rate of about 2.4 million shots a day. That assumes it goes beyond the 23 million that have already been bumped. Biden said the government would be sending 10 million shots a week for the next three weeks. That is an increase of almost 20% over what is currently being delivered.

Johnson & Johnson expects results for its Covid vaccine early next week. CNBC’s Meg Tirrell said the company conducted its test on three continents, including South Africa and Brazil, where the highly communicable new variants were identified. This means that Johnson & Johnson’s results could provide vital information on how vaccines developed around the original strain of Covid work against the emerging ones.

Dr. Bruce Becker, associate professor of behavioral medicine and social sciences at Brown University’s School of Public Health, told The News with Shepard Smith that the Johnson & Johnson vaccine requires only one shot and therefore achieves immunity in 14 to 21 years will days.

“The J&J vaccine can vaccinate twice the number of patients for any given vaccine supply – twice the coverage and immunity in less than half the time,” Becker said. “That is a much greater efficiency in blocking the spread of Covid.”

Jha told host Shepard Smith that a single dose would “greatly” aid in vaccination effort, but questioned the company’s manufacturing capacity.

“I think one of the less clear questions is how much stock of J&J vaccines we have.” asked Jha. “There have been some reports that it didn’t go that well, production didn’t go that well, but either way, a dose is so much easier to give as a vaccine.”

The Centers for Disease Control and Prevention published a study Tuesday that found that Covids spread in schools is very low with the right precautions. Jha stated that the US can open schools across the country, but “we have to do it” with preventive measures that include masks and effective ventilation.

Becker underlined the importance of preventive measures and even said that non-compliant students should be excluded from school.

“Masking work, social distancing work, and the deadly misinformation circulated by the previous government and their voices created our current dilemma,” Becker said. “Schools can be opened if the rules are followed exactly.”

Biden said Tuesday “it will be months before we can vaccinate the majority of Americans” and that “masks not vaccines” are the best defense against Covid as Americans wait for their vaccine.

Categories
Health

What If You By no means Get Higher From Covid-19?

At least anecdotally, some long-distance drivers experience the type of virus reactivation that describes climates. In late October, seven months after contracting the coronavirus, Lauren Nichols developed shingles – a reactivation of the virus that causes chickenpox. The “out of this world” episode of searing nerve pain sent her to the emergency room. A lesion developed on the cornea of ​​her left eye that threatened her vision. Antiviral drugs helped control her shingles. Nichols, an administrator of a Long Covid support group, told me that reactivation of Epstein-Barr, cytomegalovirus and other herpes viruses is happening in a small but significant percentage of long distance drivers on the site.

A similar argument about what drives chronic symptoms – persistent infection versus persistent inflammation from previous infection – plays an important role in the Lyme disease study. Some people infected with Borrelia burgdorferi, the tick-borne bacterium that causes Lyme, do not recover even after taking antibiotic treatment. Patients may refer to this condition as “chronic Lyme disease,” but doctors prefer to refer to it as “post-treatment Lyme disease syndrome” because they are unsure whether the infection is still present. As with ME / CFS research, the debate over the root cause of this post-Lyme disease has polarized the field for years.

There are other similarities as well. The Lyme problem is not recognized, but it is immense. It is estimated that 329,000 people become infected with B. burgdorferi each year. About 10 percent of people treated with antibiotics develop persistent symptoms, including fatigue, pain, and occasionally nervous system disorders such as dysautonomia – heart rate, blood pressure, and other basic body functions out of order. It seems to affect women more than men, it has long been dismissed as psychological and the long-term illness is often judged to be worse than the acute infection.

Like ME / CFS, post-Lyme syndrome does not have a biological marker that allows a specific diagnosis. The three non-mutually exclusive ideas about what causes long-term symptoms are roughly the same as for ME / CFS: a persistent infection (or maybe just debris from the Lyme spirochetes); an autoimmune disease or inflammatory dysfunction that is caused by the infection and that persists after the bacteria go away; or changes in the nervous system reflecting Jarred Younger’s idea of ​​”angry microglia” but described by Lyme researchers as “raising central nervous system awareness”. Perhaps the infection changes the way the brain functions in such a way that stimuli that were once easily bearable – pain, light, sound – become unbearable.

The parallels between ME / CFS and Lyme confirm the belief that many different infections – including Lyme spirochetes – can trigger long-term debilitating syndromes. It’s a lesson we as a society may have forgotten, said Allen Steere, a Lyme expert and rheumatologist at Harvard Medical School. “Now we have infected millions and it is becoming clear to people that this type of problem can follow.”

It’s a crazy prospect, but for a long time Covid may not be a single syndrome at all. It could, as seems to be the case with ME / CFS, be a series of problems linked in various ways to an initial trigger – in Covid’s case, the invasion of the human body by a virus believed to be it is originally native to bats. ME / CFS doctors and researchers have faced this frustrating complexity for years. It is an inevitable challenge in treating any condition, be it ME / CFS or Long Covid, whose diagnosis is based almost entirely on subjective reporting of symptoms. After all, there are many ways in which you can cause symptoms like fatigue, brain fog, and even dysautonomia. As Peter Rowe puts it, treating ME / CFS is like peeling an artichoke. “They are trying to remove treatable layers of problems and see what the essence is,” he told me.

In the case of ME / CFS, scientists have identified several more leaves of the proverbial artichoke – a lucky bag of treatable, somewhat opaque conditions that appear to be associated with it. One is mast cell activation syndrome, which can cause fatigue, pain, and problems with thinking and memory. An infection can sometimes trigger it. Another is small fiber neuropathy, a condition in which the body’s nerves misfire and can die, causing pain, fatigue, and disruption of basic body functions such as breathing. Infections can sometimes trigger it, and given the current description of Lang Covid symptoms, Anne Louise Oaklander, a pioneer in understanding this neuropathy, suspects it also occurs in long-distance drivers. “Small fiber neuropathy is usually treatable,” said Oaklander, “and in some cases curable.”

Categories
Health

UK’s coronavirus dying toll surpasses 100,000

Paramedics work in an ambulance parked outside the Royal London Hospital in east London on January 21, 2021.

DANIEL LEAL-OLIVAS | AFP | Getty Images

LONDON – The official UK death toll from the coronavirus pandemic hit 100,000 on Tuesday. That was the grim milestone reached as a recent surge in infections continued to put pressure on hospitals and emergency services.

The latest government data showed an additional 1,631 people had died within 28 days of testing positive. To date, the UK has had over 3.6 million infections.

The UK has been particularly hard hit by the pandemic that hit the country almost a year ago. The first two reported Covid-19 cases occurred on January 31, 2020 in the tourist city of York, in northern England.

Now, a year later, the UK is in its third national lockdown, battling an increase in infections and subsequent hospitalizations and deaths caused by a more communicable variant of the virus. The mutation, first discovered in the south-east of England in September 2020, then spread to London and is now responsible for the majority of new infections in Great Britain. This has resulted in more people going to the hospital and putting the health system under extreme pressure.

The UK has the fifth highest number of cases in the world after the US, India, Brazil and Russia, according to Johns Hopkins University. France with around 3.1 million cases, followed by Italy and Spain with around 2.5 million cases each, but the UK has a higher death toll than its European neighbors.

Experts have attributed the UK’s harsh experiences during the pandemic to a number of factors, including the subsequent initial lockdown that caused it to struggle to gain control of the fast-spreading virus and hesitation about the following two lockdowns when the cases had already increased again, periods of relaxation. A poor testing and traceability system was also a factor.

British Prime Minister Boris Johnson said Tuesday that he had taken full responsibility for everything his administration did.

“What I can tell you is that we have really done what we can and continue to do everything we can to minimize the loss of life and suffering,” he said at a daily press conference.

On a more positive note, the UK is leading the world in its coronavirus vaccination campaign. It was the first country to approve and introduce the vaccine developed by Pfizer and BioNTech, and the vaccine developed by AstraZeneca and Oxford University.

After the vaccination campaign started in early December, weeks before the EU, she has now vaccinated a large part of her priority groups. elderly and healthcare / nursing home workers and is now offering the vaccine to those over 70 and anyone at extreme risk.

To date, it has vaccinated over 6.8 million people with at least the first dose of a vaccine.